 The primary outcome for the eventual trial that we will also measure in this pilot is hospitalization Specifically, we will assess if 75 of participants can be randomized within 72 hours, if 90 of participants receive all doses of study medication, and if there is complete follow up in 95 of participants. If the pilot study meets our feasibility criteria, it will be deemed appropriate to plan for the larger trial, which we anticipate will require 1,590 participants. If it appears that any of these will not met as we are conducting the trial, we will modify the protocol accordingly to ensure that they are. 